COVID-19: BQ.1.1 Variant, Hiding in Plain Sight in the United
States.
The BQ.1.1 is the great grandson (or daughter) of BA.5. Thus, once it
became apparent in the last few weeks that the variant is having a
significant impact the data was separated. The BQ.1.1 is doubling every
week and is on track to become the dominant variant in our variant soup.
Europe is undergoing a surge in infections. The BQ.1 and BQ.1.1 are
dominant strains. The hospital association in Germany has asked their
government to mandate masks in indoor settings. Despite the looming
dangers, only 4.5% of the United States’ population have obtained the
Bivalent BA.5 booster. Misinformation is key. The most recent came from
the Florida Dept. of Health which assumed “a high level of global
immunity to COVID-19” and recommended against vaccination of 18- to
39-year-old males. However, myocarditis, as found in their study still
pales in comparison to that from an infection. Studies have found
infections having a 7 to 11 times higher chance of myocarditis compared
to that which can occur from vaccinations, plus with vaccinations and
boosters, the myriad of damage from Long COVID can be avoided. Recent
studies have found Long COVID to affect between 28% and 48% of
individuals with symptomatic COVID-19 and that boosters can cut the
chances of developing Long COVID by almost half. This underscores the
importance of obtaining the bivalent BA.5 booster. For most individuals,
the benefits of the booster far outweigh risks. Jack Pattie Show. Oct.
17, 2022.
|